Digital Health Simplified

Valencell is an acclaimed innovator in digital health solutions with a focus on chronic disease management. We develop and deliver medical-grade digital health solutions that are intuitive, accurate, and easy to incorporate into everyday health routines. Valencell’s patented biometric sensor technology, proprietary algorithms, and analytics, used by third-party wearable solutions on the market today, have been clinically validated in thousands of diverse participants over many years.

Best known for our award-winning motion-tolerant heart rate monitoring inventions, now proliferated in tens of millions of wearable devices, we have built upon this foundational technology to address unmet needs in the prevention and management of chronic diseases, such as hypertension, respiratory disease, and diabetes.

Recent innovations have propelled Valencell from the sports/fitness marketplace into the consumer medical sector, where we have now built upon our legacy technology to enable our own branded solutions, targeting over-the-counter use.

A venture-backed enterprise, Valencell’s investors include Best Buy, Halma, GII Fund, TDF, Sonion, and WSJ Joshua Fund. Our company has also been supported by millions in government grants from the National Institutes of Health (NIH), the National Science Foundation (NSF), and the North Carolina Board of Science, Technology & Innovation. Clinical collaborators have included the Duke Center for Living, North Carolina Research Campus, Campbell University, and numerous industry leaders in medical solutions and pharma.